ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Cevostamab Biosimilar - Anti-FCRL5 Antibody - Low endotoxin, Azide free (A323356)

Recombinant human monoclonal antibody to FCRL5 for ELISA, FACS, Functional Assay and In Vivo.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 12-18 business days.
Name
Cevostamab Biosimilar - Anti-FCRL5 Antibody - Low endotoxin, Azide free
Description
Recombinant human monoclonal antibody to FCRL5.
Applications
ELISA, FACS, Functional Assay, In Vivo
Reactivity
Human, Cynomolgus Macaque
Host
Human
Clonality
Monoclonal
Isotype
IgG1
Light Chains
kappa
Conjugate

Unconjugated

Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 145 kDa.
Purity
> 91.59% (by SDS-PAGE and SEC-HPLC).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Synonyms
BXMAS1, CD307e, Fc receptor homolog 5, Fc receptor-like protein 5, FcR-like protein 5, FCRH5, Immune receptor translocation-associated protein 2, IRTA2
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Cevostamab Biosimilar - Anti-FCRL5 Antibody - Low endotoxin, Azide free (A323356)? Please let us know so that we can list the citation on this page.

Alternative products to Cevostamab Biosimilar - Anti-FCRL5 Antibody - Low endotoxin, Azide free (A323356)

Proteins predicted to interact with FCRL5

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
82.9% Relevancy Score
81.7% Relevancy Score
78.6% Relevancy Score
74.3% Relevancy Score
74.3% Relevancy Score
72.1% Relevancy Score
70.2% Relevancy Score
70.2% Relevancy Score
68.2% Relevancy Score